Celltrion
068270.KS
#789
Rank
โ‚น3.144 T
Marketcap
โ‚น13,712
Share price
1.49%
Change (1 day)
25.65%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2026 (TTM): โ‚น92.43 Billion

According to Celltrion 's latest financial reports the company's current earnings are โ‚น3.13 Billion. In 2025 the company made an earning of โ‚น82.09 Billion, an increase over its 2024 earnings that were of โ‚น44.52 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น92.43 B12.6%
2025 โ‚น82.09 B84.38%
2024 โ‚น44.52 B-8.89%
2023 โ‚น48.86 B6.61%
2022 โ‚น45.83 B-21.93%
2021 โ‚น58.71 B10.28%
2020 โ‚น53.24 B65.38%
2019 โ‚น32.19 B16.74%
2018 โ‚น27.57 B-33.93%
2017 โ‚น41.74 B106.65%
2016 โ‚น20.19 B25.18%
2015 โ‚น16.13 B-6.4%
2014 โ‚น17.23 B47.49%
2013 โ‚น11.68 B-33.58%
2012 โ‚น17.59 B
2010 โ‚น9.15 B72.52%
2009 โ‚น5.30 B258.3%
2008 โ‚น1.48 B